These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 10969799

  • 1. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.
    Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799
    [Abstract] [Full Text] [Related]

  • 2. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T, Mashiko M, Takita K, Otake T, Endo Y, Sekikawa K, Takenoshita S.
    J Exp Clin Cancer Res; 2003 Jun 15; 22(2):315-20. PubMed ID: 12866583
    [Abstract] [Full Text] [Related]

  • 3. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, Rechberger T, Jakowicki JA, Krajewska WM.
    Gynecol Oncol; 2004 Oct 15; 95(1):173-80. PubMed ID: 15385128
    [Abstract] [Full Text] [Related]

  • 4. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH, Park YJ, Park JG.
    Clin Cancer Res; 2000 Feb 15; 6(2):536-40. PubMed ID: 10690536
    [Abstract] [Full Text] [Related]

  • 5. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
    Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE.
    Cancer Res; 1998 Dec 01; 58(23):5329-32. PubMed ID: 9850059
    [Abstract] [Full Text] [Related]

  • 6. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, Wasan HS, Roylance RR, Bodmer WF, Tomlinson IP.
    Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9719-23. PubMed ID: 11481457
    [Abstract] [Full Text] [Related]

  • 7. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
    Tanaka S, Mori M, Mafune K, Ohno S, Sugimachi K.
    Br J Cancer; 2000 May 14; 82(9):1557-60. PubMed ID: 10789724
    [Abstract] [Full Text] [Related]

  • 8. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR, Salhab KF, McGrath P, Strodel W, Freeman JW.
    Anticancer Res; 2000 May 14; 20(1A):43-51. PubMed ID: 10769633
    [Abstract] [Full Text] [Related]

  • 9. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun 14; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 10. A novel SMAD4 gene mutation in seminoma germ cell tumors.
    Bouras M, Tabone E, Bertholon J, Sommer P, Bouvier R, Droz JP, Benahmed M.
    Cancer Res; 2000 Feb 15; 60(4):922-8. PubMed ID: 10706106
    [Abstract] [Full Text] [Related]

  • 11. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K, Bennett WP.
    Oncogene; 1997 Jul 03; 15(1):117-22. PubMed ID: 9233784
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 13. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T.
    Clin Cancer Res; 2005 May 01; 11(9):3191-7. PubMed ID: 15867212
    [Abstract] [Full Text] [Related]

  • 14. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 15. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S, Mogi A, Tani M, Osawa H, Sunaga H, Kakegawa H, Yanagita Y, Koida T, Kimura M, Fujita KI, Kato H, Kato R, Nagamachi Y.
    Oncol Rep; 1998 Aug 01; 5(2):367-71. PubMed ID: 9468559
    [Abstract] [Full Text] [Related]

  • 16. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.
    Watanabe Y, Kinoshita A, Yamada T, Ohta T, Kishino T, Matsumoto N, Ishikawa M, Niikawa N, Yoshiura K.
    J Hum Genet; 2002 Aug 01; 47(9):478-83. PubMed ID: 12202987
    [Abstract] [Full Text] [Related]

  • 17. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T.
    Clin Cancer Res; 2001 Jun 01; 7(6):1618-26. PubMed ID: 11410498
    [Abstract] [Full Text] [Related]

  • 18. Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture.
    Zhao J, Lee M, Smith S, Warburton D.
    Dev Biol; 1998 Feb 15; 194(2):182-95. PubMed ID: 9501027
    [Abstract] [Full Text] [Related]

  • 19. Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.
    Maliekal TT, Antony ML, Nair A, Paulmurugan R, Karunagaran D.
    Oncogene; 2003 Jul 31; 22(31):4889-97. PubMed ID: 12894231
    [Abstract] [Full Text] [Related]

  • 20. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas.
    Ikeda H.
    Brain Tumor Pathol; 2006 Apr 31; 23(1):7-12. PubMed ID: 18095113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.